SCHEMBL30140909

SCHEMBL30140909

CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ GLP1R P43220 8/20 0.50
▸ SCTR P47872 1/20 0.50
▸ TFPI P10646 1/20 0.47
▸ GCGR P47871 1/20 0.47
▸ VIPR1 P32241 1/20 0.47
▸ APLNR P35414 1/20 0.47
▸ NPY4R P50391 3/20 0.47
▸ NPY1R P25929 2/20 0.47
▸ NPY2R P49146 2/20 0.47
▸ NPY5R Q15761 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30905999 0.94 NPY4R (0.51) GLP1RSCTRVIPR1NPY4RNPY1R
SCHEMBL30140911 0.94 GLP1R (0.51) GLP1RSCTRTFPIGCGRVIPR1
SCHEMBL30432968 0.91 VIPR1 (0.59) GLP1RVIPR1
SCHEMBL30974552 0.91 NPY4R (0.57) GLP1RSCTRVIPR1NPY4RNPY1R
SCHEMBL29659782 0.91 NPY4R (0.48) GLP1RSCTRAPLNRNPY4RNPY1R
SCHEMBL30484003 0.90 VIPR1 (0.50) GLP1RSCTRTFPIGCGRVIPR1
SCHEMBL29707438 0.90 TFPI (0.62) GLP1RSCTRTFPIGCGRVIPR1
SCHEMBL30495611 0.89 APLNR (0.53) GLP1RSCTRTFPIAPLNR
SCHEMBL30462069 0.89 EGFR (0.46) NPY4RNPY1RNPY2R
SCHEMBL31032683 0.88 GLP1R (0.51) GLP1RSCTRTFPIGCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230050804-A1 USE OF CCDC157 GENE AND MUTANT GENES THEREOF AS MOLECULAR MARKERS IN DIAGNOSIS OF MALE INFERTILITY DISEASES ZHEJIANG UNIVERSITY (CN) 2023-02-16 — — US disclosed
Send feedback